Results 101 to 110 of about 1,956 (168)

Long-read genome sequencing resolves the breakpoints of a chromosome 8;22 balanced translocation in NF2-related schwannomatosis. [PDF]

Sci Rep
Montini M, Bonacchi L, Sidoti D, Cuccoli S, Pantaleo M, Peron A, Scuffi I, DosSantos MF, Nassini R, De Logu F, Papi L.   +10 more
europepmc   +1 more source

Characterizing Pain in Peripheral Nerve Tumors: Interim Results from a Prospective Bicenter Cohort. [PDF]

Cancers (Basel)
Grübel N, Uerschels AK, Wrede K, Dengler NF, Mayer B, Wirtz CR, Pedro MT, Peripheral Nerve Tumor Study (PNTR) Study Group.   +7 more
europepmc   +1 more source

Schwannomatosis tumor modeling: progress and prospects for translational research. [PDF]

J Biol Eng
Madison MS, Xu H, Gonzalez-Vargas Y, Yonk MG, Thompson CM, Haney H, Babbitt D, Du Y, Hirbe AC, Boulis NM, Bai RY, Lei K.   +11 more
europepmc   +1 more source

Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT). [PDF]

BMJ Open
Campbell S, Beaney K, Hosking J, Sorrell L, Allgar V, Aspinall PJ, Ammoun S, Evans DG, Hanemann CO, Kingdon S.   +9 more
europepmc   +1 more source

De novo neurofibromatosis type 2-related schwannomatosis in a child presenting with intraocular signs as initial manifestations. [PDF]

Am J Ophthalmol Case Rep
Vienne-Jumeau A, Bijon J, Waintraub S, Caputo G, Metge F.   +4 more
europepmc   +1 more source

From genes to therapy: navigating the complex landscape of neurofibromatosis management in Canada through advanced diagnostic, targeted therapies, and holistic care. [PDF]

Orphanet J Rare Dis
Zhao VSC.
europepmc   +1 more source

Ex Vivo Characterization Studies Identify Candidate Therapies for the Individualized Care of <i>NF2</i>-Related Schwannomatosis. [PDF]

Cancers (Basel)
Hass EW, Nagel A, Scott AJ, Allaway R, Hardin HM, Hayes HM, Huelbes L, Sutton AW, Oliveira SA, Pei M, Telischi FF, Ragheb J, McKinnon M, Khatib Z, Bauer M, Dinh CT, Fernandez-Valle C.   +16 more
europepmc   +1 more source

Recurrent schwannomatosis with mosaic SMARCB1 loss: A case report. [PDF]

Exp Ther Med
Lakhina Y, Lim MA, Yonk MG, Campbell M, Tora MS, Du Y, Koshkin S, Lei K, Boulis NM.   +8 more
europepmc   +1 more source

SMARCB1-related schwannomatosis and other SMARCB1-associated phenotypes: clinical spectrum and molecular pathogenesis. [PDF]

Fam Cancer
Kehrer-Sawatzki H, Cooper DN.
europepmc   +1 more source

A systematic review and meta-analysis of outcomes following active surveillance, surgery and radiotherapy of meningiomas in NF2-related schwannomatosis. [PDF]

Neurooncol Adv
Sheppard J, Kannan S, Halliday J, Rutherford S, Lavin T, Forde C, Smith MJ, Evans G, King AT, Islim AI, Pathmanaban ON.   +10 more
europepmc   +1 more source